Smart Money Alert

Eris Lifesciences Limited

New PositionQuarterly

ERISPharmaceuticalsMarket Cap₹17K Cr

Stake

1.03%

HSBC Mutual Fund

Mutual Fund

The move

HSBC Mutual Fund entered Eris Lifesciences Limited with 14,25,613 shares, a 1.03% stake worth ₹207.57 crore at ₹1455.40 apiece.

About Eris Lifesciences Limited

Visit stock

A pharmaceutical manufacturer and marketer, ERIS Lifesciences produces branded and generic drugs across multiple therapeutic areas including cardiovascular, gastroenterology, and anti-infective segments. The company operates manufacturing facilities and distributes medications through established distribution networks to serve both domestic and international markets. It focuses on developing and delivering cost-effective pharmaceutical formulations for diverse patient populations.

About HSBC Mutual Fund

Visit investor

Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.

Get the next move the moment it happens.

Follow HSBC Mutual Fund and Eris Lifesciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Eris Lifesciences Limited shareholders HSBC Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Eris Lifesciences Limited

UTI Mutual FundDecreased

UTI Mutual Fund decreased its stake in Eris Lifesciences from 1.92% to 1.58% by selling 4,67,922 shares. The value of shares sold is ₹68.09 Cr at ₹1455.40 apiece.

19 Jul 2026

Franklin Templeton Mutual FundIncreased

Franklin Templeton Mutual Fund increased its stake in Eris Lifesciences from 4.06% to 4.29%, buying 329,077 shares. In July, Franklin Templeton Mutual Fund had bought 10.94 lakh shares of Eris Lifesciences for ₹109.42 crore at ₹1,000.04 apiece.